Tat'Yana Ivanovna Torkhovskaya

Tat'Yana Ivanovna Torkhovskaya

Auto-generated profile, based on publicly available information

Tat'Yana Ivanovna Torkhovskaya

Laboratory of Phospholipid Transport Systems and Nanomedicines, Institute of Biomedical Chemistry, 119121 Moscow, Russia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
TTT. I. Torkhovskaya
T. I. Torkhovskaya
OIO. M. Ipatova
O. M. Ipatova
TZT. S. Zakharova
T. S. Zakharova
MKM. M. Kochetova
M. M. Kochetova
EKE. M. Khalilov
E. M. Khalilov
There is increasing evidence that different phospholipids are involved in regulation of various cell processes and cell-cell interactions. Lysophospholipids (lysophosphatidic acid,...

1 September 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
VKVasily A. Kudinov
Vasily A. Kudinov
TTTatiana I. Torkhovskaya
Tatiana I. Torkhovskaya
TZTamara S. Zakharova
Tamara S. Zakharova
GMGalina E. Morozevich
Galina E. Morozevich
Rafael ArtyushevRafael Artyushev
Rafael Artyushev
SMSergey Markin
Sergey Markin
The efficiency of cholesterol efflux from cells promoted by high-density lipoproteins (HDLs) depends on HDL concentration and functional properties. The term "dysfunctional HDL" describes HDLs with impaired protective properties. Cholesterol efflux capacity (CEC) of HDL is reduced in patients with atherosclerosis, but the exact mechanisms underlying this impairment are not well characterized. Enriching HDLs with phospholipids (PLs) improves CEC. Herein, we assessed the potential of PL nanoparticles in improving HDL functionality. We lipidated HDL subfractions by incubating with PL nanoparticles containing soybean polyunsaturated phosphatidylcholine. Incubating blood plasma with PL nanoparticles resulted in the dose-dependent lipidation of all HDL subfractions. Changes in apolipoprotein A1 (apoA-1) and PL concentrations were the most prominent in the HDL2 fraction. Concentrations of PL in the HDL3 fraction and the fraction with a density > 1.21 g/mL increased by 30-50%, whereas apoA-1 levels decreased. We hypothesized that PL nanoparticles may cause HDL remodeling that can improve their functions. The CECs of lipidated HDLs were analyzed by incubating apolipoprotein B (apoB)-depleted plasma with 3H-cholesterol-labeled THP-1 macrophages. The findings revealed a two-fold increase in cholesterol efflux compared with native apoB-depleted plasma. Moreover, intravenous administration of PL nanoparticles restored lipid profiles and effectively protected blood vessels from atherosclerosis progression in cholesterol-fed rabbits compared with that of fenofibrate and atorvastatin. PL nanoparticles also protected against atherosclerosis and decreased the atherogenic index. Altogether, these results indicate that PL nanoparticles can be used to correct the lipid composition and CEC of HDLs. DATA AVAILABILITY: Additional data can be provided upon reasonable request from the date of publication of this article within 5 years. The request should be sent to the author-correspondent at the address cd95@mail.ru.

Verified
Journal Article
Open access
PDF file
VKVasily A. Kudinov
Vasily A. Kudinov
OAOlga Yu. Alekseeva
Olga Yu. Alekseeva
TTTatiana I. Torkhovskaya
Tatiana I. Torkhovskaya
KBKonstantin Konstantinovich Baskaev
Konstantin Konstantinovich Baskaev
Rafael ArtyushevRafael Artyushev
Rafael Artyushev
SMSergey Markin
Sergey Markin
It is well known that blood lipoproteins (LPs) are multimolecular complexes of lipids and proteins that play a crucial role in lipid transport. High-density lipoproteins (HDL) are a class of blood plasma LPs that mediate reverse cholesterol transport (RCT)—cholesterol transport from the peripheral tissues to the liver. Due to this ability to promote cholesterol uptake from cell membranes, HDL possess antiatherogenic properties. This function was first observed at the end of the 1970s to the beginning of the 1980s, resulting in high interest in this class of LPs. It was shown that HDL are the prevalent class of LPs in several types of living organisms (from fishes to monkeys) with high resistance to atherosclerosis and cardiovascular disorders. Lately, understanding of the mechanisms of the antiatherogenic properties of HDL has significantly expanded. Besides the contribution to RCT, HDL have been shown to modulate inflammatory processes, blood clotting, and vasomotor responses. These particles also possess antioxidant properties and contribute to immune reactions and intercellular signaling. Herein, we review data on the structure and mechanisms of the pleiotropic biological functions of HDL from the point of view of their evolutionary role and complex dynamic nature.

1 July 2006 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
OIO. M. Ipatova
O. M. Ipatova
TTT. I. Torkhovskaya
T. I. Torkhovskaya
TZT. S. Zakharova
T. S. Zakharova
EKE. M. Khalilov
E. M. Khalilov
This review considers various functional aspects of cell sphingolipids (sphingomyelin, ceramides) and lysosphingolipids (sphingosine-1-phosphate (S1P) and sphingosine phosphorylcholine). Good...

1 February 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TTTatyana I. Torkhovskaya
Tatyana I. Torkhovskaya
LKLyubov V. Kostryukova
Lyubov V. Kostryukova
YTYulia Tereshkina
Yulia Tereshkina
ETElena G. Tikhonova
Elena G. Tikhonova
GMGalina E. Morozevich
Galina E. Morozevich
PAPankratov Andrey
Pankratov Andrey
A promising direction in Biopharmaceuticals is the development of specific peptide-based systems to improve drug delivery. This approach may increase tumor specificity and drug penetration into the target cell. Similar systems have been designed for several antitumor drugs. However, for photodynamic therapy drugs, such studies are not yet enough. Previously, we have developed a method of inclusion of chlorin e6 (Ce6), a photosensitizer used in photodynamic therapy, in phospholipid nanoparticles with a diameter of up to 30 nm, and reported an increase in its effectiveness in the experiments in vivo. In this work, we propose to modify a previously developed delivery system for Ce6 by the addition of cell-penetrating (R7) and/or targeting NGR peptides. The interaction of the compositions developed with HepG2 and MCF-7 tumor cells is shown. The expression of CD13 protein with affinity to NGR on the surface of these cells has been studied using flow cytometry. The expression of this protein on the HepG2 cells and its absence on MCF-7 was demonstrated. After incubation of tumor cells with the resulting Ce6 compositions, we evaluated the cellular accumulation, photoinduced, and dark cytotoxicity of the drugs. After irradiation, the highest level of cytotoxicity was observed when R7 peptide was added to the system, either alone or in combination with NGR. In addition to R7, the NGR-motif peptide increased the internalization of Ce6 in HepG2 cells without affecting its photodynamic activity. In this work we also discuss possible mechanisms of action of the cell-penetrating peptide when attached to phospholipid nanoparticles.

24 March 2010 in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
Verified
Journal Article
Closed access
PDF file
OIO. M. Ipatova
O. M. Ipatova
TTT. I. Torkhovskaya
T. I. Torkhovskaya
NMN. V. Medvedeva
N. V. Medvedeva
VPV. N. Prozorovsky
V. N. Prozorovsky
NIN. D. Ivanova
N. D. Ivanova
AAA. I. Archakov
A. I. Archakov
Recent studies in nanotechnology resulted in the development of novel formulations with improved bioavailability. This is especially important for oral administered drugs as the most convenient formulations for administration to patients. The review considers processes occurring in the gastro-intestinal (GI) tract during oral administration of drugs. The increase of bioavailability of the drug may be achieved through designing novel formulations according to the specific drug properties. These include capsules that release pharmaceutical agents at various parts of the GI tract, floating systems that prolong the presence of the drug in stomach, maximally dispersed forms containing surface-active soluble polymers or micelles that carry poor-soluble drugs inside their non-polar core, agents that facilitate tight junction opening, such as caprate and chitosan, and lipid-based formulations. The own data show the stimulating influence of phospholipid nanoparticles on peroral absorption of the drug, indomethacin, in rats and on passage of transport marker and drugs through Caco-2 cell monolayer in vitro. The review summarizes current understanding of factors that influence the bioavailability of the oral drug formulations, currently used models for pharmacokinetic studies, and various approaches to developing novel pharmaceutical formulations that increase the bioavailability of the drugs.